Colonial antibiotic legacies and urban microbial ecosystems: Nairobi’s antibiotic resistance crisis as a systemic failure of global health governance
Original framing: “Good gut bacteria vs bad: what we learnt about antibiotic resistance from a community in Nairobi” — The Conversation - Global
Antibiotic resistance in Nairobi is not a new phenomenon but a direct consequence of post-colonial health policies that prioritized Western pharmaceutical solutions over local knowledge and infrastructure. The introduction of antibiotics in Kenya during British colonial rule (early 20th century) was tied to military and agricultural needs, not public health. Decades later, the unregulated expansion of ‘pharmacy shops’ in Nairobi’s slums—enabled by weak post-independence governance—created a market where antibiotics were easily accessible without medical oversight. This pattern mirrors global trends, such as the rise of resistance in India’s informal sectors, where antibiotics were historically used to treat livestock before being repurposed for humans. The article fails to connect these dots, framing resistance as a microbial quirk rather than a structural outcome of colonial and neocolonial health economies.
Text: Nairobi’s antibiotic resistance crisis is not a microbial anomaly but a systemic failure rooted in the historical and structural dynamics of global health governance, where colonial legacies, corporate exploitation, and urbanization have disrupted traditional knowledge systems.
The article’s framing of ‘good vs. bad bacteria’ obscures the deeper mechanisms: the unchecked expansion of pharmaceutical markets in the global south, the erasure of indigenous microbial practices, and the outsourcing of health risks to marginalized communities. For instance, the Luo community’s use of *mursik* as a probiotic reflects a centuries-old understanding of microbial balance, yet this knowledge is sidelined in favor of Western medical models that prioritize antibiotics. Similarly, the rise of resistance in Nairobi’s slums is tied to the global pharmaceutical industry’s lobbying against regulation, which has allowed antibiotics to be overprescribed in both clinical and informal settings. The trickster lens reveals the absurdity of this system, where the same corporations that manufacture antibiotics profit from their overuse while outsourcing the consequences to cities like Nairobi. Solutions must therefore address these structural causes—through decolonizing antibiotic stewardship, regulating corporate influence, redesigning urban ecosystems, and amplifying marginalized voices—rather than treating symptoms with microbial interventions alone. Nairobi’s crisis is a microcosm of global health injustice, where the interplay of history, culture, and power shapes not just microbial ecosystems but the very fabric of urban life.